No Data
No Data
Wells Fargo Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $110
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and Irhythm Technologies (IRTC)
All You Need to Know About IRhythm Technologies (IRTC) Rating Upgrade to Buy
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)
Irhythm Technologies (IRTC) Receives a Buy From Wells Fargo
IRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing